Glenmark Pharma Q2 profit rises 72%, revenue up 76%
after close1 source ↓written by the desknot a recommendation
- year-on-year
- 72.3%
- Revenue surged
- 76.1%
- ₹6,047 cr
- with a margin
- ₹2,360 cr
- from 17.5
- 39%
Glenmark Pharmaceuticals reported a net profit of ₹610 cr, up 72.3% year-on-year, for Q2. Revenue surged 76.1% to ₹6,047 cr. The EBITDA rose to ₹2,360 cr with a margin expansion to 39% from 17.5%. This strong performance may boost investor sentiment in the pharma sector. 📈
Not investment advice. For informational purposes only.